astrazeneca glp 1 drug signs up to US$18.5 billion obesity deal with China's CSPC Type 2 Diabetes: AstraZeneca's New

astrazeneca glp 1 drug

astrazeneca glp 1 drug signs up to US$18.5 billion obesity deal with China's CSPC Type 2 Diabetes: AstraZeneca's New

Name: astrazeneca glp 1 drug signs up to US$18.5 billion obesity deal with China's CSPC Type 2 Diabetes: AstraZeneca's New
Brand: decb-eg.com
SKU: 82916194017
Price: 21.17 USD
Availability: InStock
Rating: 4.5571 (18 reviews)

SKU: 82916194017

4.6

EUR21.17 EUR45.17

Pay in 4 interest-free payments of $5.29 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Supports Cognitive Function Oxidative stress is a major contributor to neurodegenerative diseases like Alzheimers and Parkinsons

Data are scarce, and are mainly found in non-clinical models

Although scientists are still figuring out how allulose lowers blood sugar and helps with overall glycemic control, preliminary research suggests that the sweetener may improve insulin sensitivity by helping a liver enzyme called glucokinase work more effectively